EAST LANSING, Mich., Nov. 5 /PRNewswire/ -- Michigan's preparedness for bioterrorism, disparities in the treatment of prostate cancer and a review of hormone replacement therapy will be among the 40 topics presented at the Michigan State Medical Society's 138th Annual Scientific Meeting (ASM) on Nov. 5-7 at the Somerset Inn in Troy.
"Bioterrorism, Chemical Terrorism and the State's Preparedness Efforts" will be presented from 8:30 a.m. to Noon on Thursday, Nov. 6. The state's leading experts in this area will cover hospital response to bioterrorism disasters and discuss possible contaminants including smallpox and monkeypox.
"Menopausal Medicine Update" will be presented from 1:30 to 5:30 p.m. on Thursday, Nov. 6. Topics will include the safety and efficacy of hormone replacement therapy (HRT), alternatives to HRT and a discussion of osteoporosis and cancers in the menopausal patient.
An "Early Bird" plenary session from 7 to 8 a.m. on Friday, Nov. 7, will review "Health Disparities in the Management of Prostate Cancer" focusing on prostate cancer in African-American men.
"For 138 years the Michigan State Medical Society has worked hard to keep its members up-to-date on new health care treatments and developments," said MSMS president Hassan Amirikia, MD, a Detroit obstetrician-gynecologist. "More than 600 physicians will attend these classes to continue their medical education to provide the very best health care for their patients."
Michigan State Medical Society
CONTACT: David Fox, Director, Public Relations of Michigan State MedicalSociety, +1-517-336-5731, or firstname.lastname@example.org